Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Chemical Information and Modeling|February 14, 2019
Both Reactivity and Accessibility Are Important in Cytochrome P450 Metabolism: A Combined DFT and MD Study of Fenamic Acids in BM3 MutantsRasmus Leth, Bogac Ercig, Lars Olsen, et al.
Future Medicinal Chemistry|May 30, 2019
Rational modulator design by exploitation of protein-protein complex structuresKanin Wichapong, Hessel Poelman, Bogac Ercig, et al.
Thrombosis and Haemostasis|January 6, 2018
Insights into 3D Structure of ADAMTS13: A Stepping Stone towards Novel Therapeutic Treatment of Thrombotic Thrombocytopenic PurpuraBogac Ercig, Kanin Wichapong, Chris P M Reutelingsperger, et al.
Haematologica|April 21, 2018
Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggersJohana Hrdinová, Silvia D'Angelo, Nuno A G Graça, et al.
The Journal of Biological Chemistry|August 30, 2021
Conformational plasticity of ADAMTS13 in hemostasis and autoimmunityBogac Ercig, Tom Arfman, Johana Hrdinova, et al.
Journal of Thrombosis and Haemostasis : JTH|August 26, 2023
Impact of N-glycan mediated shielding of ADAMTS-13 on the binding of pathogenic antibodies in immune thrombotic thrombocytopenic purpuraTim Postmus, Nuno A G Graça, Juliana Ferreira de Santana, et al.
Haematologica|November 2, 2020
Modifying ADAMTS13 to modulate binding of pathogenic autoantibodies of patients with acquired thrombotic thrombocytopenic purpuraNuno A G Graça, Bogac Ercig, Leydi Carolina Velásquez Pereira, et al.
European Journal of Haematology|May 16, 2018
Child-onset thrombotic thrombocytopenic purpura caused by p.R498C and p.G259PfsX133 mutations in ADAMTS13An-Sofie Schelpe, Christelle Orlando, Bogac Ercig, et al.
Hemasphere|September 5, 2020
Understanding the Health Literacy in Patients With Thrombotic Thrombocytopenic PurpuraLeydi C Velasquez Pereira, Bogac Ercig, Kadri Kangro, et al.
Blood|February 5, 2021
N-glycan-mediated shielding of ADAMTS13 prevents binding of pathogenic autoantibodies in immune-mediated TTPBogac Ercig, Nuno A G Graça, Kadri Kangro, et al.
Pageof 2